Akron, Ohio Establishes "Biotechnology Bridge" With Helsinki, Finland
04/28/2010
Plusquellic said the partnership's mission is to act as "collaborative partners."
"We will work to establish mutual benefits in the areas of biomedical research and life science technology commercialization," Plusquellic said. "It means that Akron companies can come to Helsinki to improve opportunities for increased sales to the European Union market."
Pajunen said Helsinki companies seeking to locate in the U.S. could find assistance through the initiative.
"Through this new collaboration project, such companies have the opportunity of reaching the local science and hospital network and financiers," Pajunen said. "On the other hand, there is a great interest in getting U.S. companies to settle in Helsinki."
The Akron Global Business Accelerator and the Helsinki Business & Science Park will execute the project. Since 2006, when Plusquellic established the Akron Biomedical Corridor, the area has received national recognition for healthcare, biomedical research, medical devices, and orthopedic excellence.
Project Announcements
Fukoku Korea Plans Henry County, Virginia, Manufacturing Operations
03/13/2026
Germany-Based Sennheiser Group Plans Nashville, Tennessee, Operations
03/12/2026
Interstate Group Expands Giles County, Virginia, Production Operations
03/11/2026
Shinhwa Auto USA Expands Auburn, Alabama, Operations
03/11/2026
General Atomics Expands Shannon, Mississippi, Production Operations
03/11/2026
Starbucks Plans Davidson County, Tennessee, Corporate Operations
03/08/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025
-
Amazon’s First Mass Timber Delivery Station Tests the Future of Low-Carbon Logistics
Q4 2025
-
Last Word: Don’t Lose by Winning
Q1 2026